1. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html#ref-43 accessed 4/16/2020.
2. Clinicaltrials.gov. accessed April 16, 2020.
3. Eculizumab (Soliris) in Covid-19 Infected Patients (SOLID-C19), 2014. Clinicaltrials.gov, accessed April 15, 2020.
4. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected2019.
5. An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD, 2019. Clinicaltrials.gove/accessed 4/19/2020.